Why the study?
Syncope is a common and challenging ED presentation with high mortality when cardiac in origin, prompting a review of recent diagnostic updates and technological developments since the 2018 ESC guidelines.
Answers are grounded in this paper and cite their sources.
This review summarizes recent advancements in the evaluation of cardiac syncope in the emergency department, emphasizing novel biomarkers, artificial intelligence, and wearable technology.
Syncope is a commonly encountered problem in the emergency department (ED), accounting for approximately 3% of presenting complaints. Clinical assessment of syncope can be challenging due to the diverse range of conditions that can precipitate the symptom. Annual mortality for patients presenting with syncope ranges from 0-12%, and if the syncope is secondary to a cardiac cause, then this figure rises to 18-33%. In ED, it is paramount to accurately identify those presenting with syncope, especially patients with an underlying cardiac aetiology, initiate appropriate management, and refer them for further investigations. In 2018, the European Society of Cardiology (ESC) updated its guidelines with regard to diagnosing and managing patients with syncope. We highlight recent developments and considerations in various components of the workup, such as history, physical examination, investigations, risk stratification, and novel biomarkers, since the establishment of the 2018 ESC guidelines. We further discuss the emerging role of artificial intelligence in diagnosing cardiac syncope and postulate how wearable technology may transform evaluating cardiac syncope in ED.
No takes yet. Share an insight, caveat, or question.
Ojha et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: